Literature DB >> 28479397

Locomotor sensitization to intermittent ketamine administration is associated with nucleus accumbens plasticity in male and female rats.

C E Strong1, K J Schoepfer1, A M Dossat1, S K Saland1, K N Wright1, M Kabbaj2.   

Abstract

Clinical evidence suggests superior antidepressant response over time with a repeated, intermittent ketamine treatment regimen as compared to a single infusion. However, the club drug ketamine is commonly abused. Therefore, the abuse potential of repeated ketamine injections at low doses needs to be investigated. In this study, we investigated the abuse potential of repeated exposure to either 0, 2.5, or 5 mg/kg ketamine administered once weekly for seven weeks. Locomotor activity and conditioned place preference (CPP) were assayed to evaluate behavioral sensitization to the locomotor activating effects of ketamine and its rewarding properties, respectively. Our results show that while neither males nor females developed CPP, males treated with 5 mg/kg and females treated with either 2.5 or 5 mg/kg ketamine behaviorally sensitized. Furthermore, dendritic spine density was increased in the NAc of both males and females administered 5 mg/kg ketamine, an effect specific to the NAc shell (NAcSh) in males but to both the NAc core (NAcC) and NAcSh in females. Additionally, males administered 5 mg/kg ketamine displayed increased protein expression of ΔfosB, calcium calmodulin kinase II alpha (CaMKIIα), and brain-derived neurotrophic factor (BDNF), an effect not observed in females administered either dose of ketamine. However, males and females administered 5 mg/kg ketamine displayed increased protein expression of AMPA receptors (GluA1). Taken together, low-dose ketamine, when administered intermittently, induces behavioral sensitization at a lower dose in females than males, accompanied by an increase in spine density in the NAc and protein expression changes in pathways commonly implicated in addiction.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  BDNF; CPP; CaMKIIα; Drug abuse; GluA1; Ketamine; Nucleus accumbens; Sensitization; Sex differences; Spine density; ΔfosB

Mesh:

Substances:

Year:  2017        PMID: 28479397      PMCID: PMC5520991          DOI: 10.1016/j.neuropharm.2017.05.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  56 in total

1.  Sensitivity and tolerance to ethanol-induced incoordination and hypothermia in HAFT and LAFT mice.

Authors:  N R Rustay; S L Boehm; G L Schafer; K E Browman; V G Erwin; J C Crabbe
Journal:  Pharmacol Biochem Behav       Date:  2001-09       Impact factor: 3.533

2.  Sex and the suffering brain.

Authors:  Constance Holden
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

3.  Automated quantification of dendritic spine density and spine head diameter in medium spiny neurons of the nucleus accumbens.

Authors:  Haowei Shen; Susan R Sesack; Shigenobu Toda; Peter W Kalivas
Journal:  Brain Struct Funct       Date:  2008-06-06       Impact factor: 3.270

Review 4.  Estradiol: a key biological substrate mediating the response to cocaine in female rats.

Authors:  Annabell C Segarra; José L Agosto-Rivera; Marcelo Febo; Natasha Lugo-Escobar; Raissa Menéndez-Delmestre; Anabel Puig-Ramos; Yvonne M Torres-Diaz
Journal:  Horm Behav       Date:  2009-12-21       Impact factor: 3.587

5.  Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization.

Authors:  R C Pierce; K Bell; P Duffy; P W Kalivas
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

6.  Clinical predictors of ketamine response in treatment-resistant major depression.

Authors:  Mark J Niciu; David A Luckenbaugh; Dawn F Ionescu; Sara Guevara; Rodrigo Machado-Vieira; Erica M Richards; Nancy E Brutsche; Neal M Nolan; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2014-05       Impact factor: 4.384

7.  Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.

Authors:  Cristina Cusin; Dawn Flosnik Ionescu; Kara Jean Pavone; Oluwaseun Akeju; Paolo Cassano; Norman Taylor; Matthias Eikermann; Kelley Durham; Michaela Ballentyne Swee; Trina Chang; Christina Dording; David Soskin; John Kelley; David Mischoulon; Emery Neal Brown; Maurizio Fava
Journal:  Aust N Z J Psychiatry       Date:  2017-01       Impact factor: 5.744

Review 8.  Multiple faces of BDNF in cocaine addiction.

Authors:  Xuan Li; Marina E Wolf
Journal:  Behav Brain Res       Date:  2014-11-15       Impact factor: 3.332

Review 9.  Signaling pathways underlying the rapid antidepressant actions of ketamine.

Authors:  Ronald S Duman; Nanxin Li; Rong-Jian Liu; Vanja Duric; George Aghajanian
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

Review 10.  Individual differences in vulnerability to drug abuse: the high responders/low responders model.

Authors:  Mohamed Kabbaj
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-10       Impact factor: 4.388

View more
  16 in total

Review 1.  Interactions between estrogen receptors and metabotropic glutamate receptors and their impact on drug addiction in females.

Authors:  Katherine R Tonn Eisinger; Kellie S Gross; Brian P Head; Paul G Mermelstein
Journal:  Horm Behav       Date:  2018-03-10       Impact factor: 3.587

2.  Ketamine sensitization: Influence of dose, environment, social isolation and treatment interval.

Authors:  Keith A Trujillo; Colleen Y Heller
Journal:  Behav Brain Res       Date:  2019-10-05       Impact factor: 3.332

3.  Repeated ketamine anesthesia during neurodevelopment upregulates hippocampal activity and enhances drug reward in male mice.

Authors:  Jianchen Cui; Xianshu Ju; Yulim Lee; Boohwi Hong; Hyojin Kang; Kihoon Han; Won-Ho Shin; Jiho Park; Min Joung Lee; Yoon Hee Kim; Youngkwon Ko; Jun Young Heo; Woosuk Chung
Journal:  Commun Biol       Date:  2022-07-15

4.  Sex differences in sub-anesthetic ketamine's antidepressant effects and abuse liability.

Authors:  Katherine N Wright; Mohamed Kabbaj
Journal:  Curr Opin Behav Sci       Date:  2018-03-02

Review 5.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

6.  Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats.

Authors:  Kristin J Schoepfer; Caroline E Strong; Samantha K Saland; Katherine N Wright; Mohamed Kabbaj
Journal:  Physiol Behav       Date:  2017-10-18

7.  Sex Differences and the Effects of Estradiol on Striatal Function.

Authors:  John Meitzen; Robert L Meisel; Paul G Mermelstein
Journal:  Curr Opin Behav Sci       Date:  2018-03-16

8.  Sex- and stress-dependent effects of a single injection of ketamine on open field and forced swim behavior.

Authors:  Paul J Fitzgerald; Savannah K Kounelis-Wuillaume; Ali Gheidi; Jonathan D Morrow; Joanna L Spencer-Segal; Brendon O Watson
Journal:  Stress       Date:  2021-02-01       Impact factor: 3.493

9.  Ketamine Differentially Attenuates Alcohol Intake in Male Versus Female Alcohol Preferring (P) Rats.

Authors:  Amir H Rezvani; Edward D Levin; Marty Cauley; Bruk Getachew; Yousef Tizabi
Journal:  J Drug Alcohol Res       Date:  2017-07-28

Review 10.  On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods.

Authors:  C E Strong; Mohamed Kabbaj
Journal:  Neurobiol Stress       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.